Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Browse
Conferences
Browse
< Back to conference highlights < Previous conference / Next conference >
Subscribe
Bookmark and Share

AACR 2015

18th - 22nd Apr 2015

Videos

News

New drug combination shows promise for breaking breast cancer resistance

(23 Apr 2015)

AACR 2015: Evidence points to fallopian-tube origins of ovarian cancers

(22 Apr 2015)

AACR 2015: PARP inhibitor combo shows early promise for patients with and without BRCA mutations

(21 Apr 2015)

AACR 2015: Olaparib–carboplatin combination showed early signs of clinical activity against ovarian and triple-negative breast cancers

(21 Apr 2015)

AACR 2015: HPV vaccine provides protection at multiple sites, even among some previously exposed

(21 Apr 2015)

AACR 2015: Metformin use may not improve pancreatic cancer survival

(21 Apr 2015)

AACR 2015: Olaparib and investigational PI3K inhibitor BKM120 combination active against ovarian and breast cancer subtypes

(21 Apr 2015)

AACR 2015: Subgroup of men with metastatic prostate cancer responded to olaparib treatment

(21 Apr 2015)

AACR 2015: Black women found to have denser breast tissue than white women

(20 Apr 2015)

AACR 2015: Antibody-drug conjugate shows early promise for patients with metastatic HER2-positive breast cancer

(20 Apr 2015)

AACR 2015: Adding PI3K inhibitor BYL719 to letrozole was safe, with early signs of activity against metastatic ER-positive breast cancer

(20 Apr 2015)

AACR 2015: Dual mTOR inhibitor-fulvestrant combo feasible, with clinical benefit for advanced breast cancer patients

(20 Apr 2015)

AACR 2015: Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive breast cancer

(20 Apr 2015)

AACR 2015: Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer, effective in some

(20 Apr 2015)

AACR 2015: Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma

(20 Apr 2015)

AACR 2015: US breast cancer cases expected to increase by as much as 50 percent by 2030

(20 Apr 2015)

AACR 2015: Extended overnight fasting may lead to reduced breast cancer risk

(20 Apr 2015)

AACR 2015: Adding a dual mTOR inhibitor to chemo may benefit some ovarian and lung cancer patients

(19 Apr 2015)

AACR 2015: 'Liquid biopsy' may help earlier detection of lung cancer treatment resistance

(19 Apr 2015)

AACR 2015: Combining two investigational immunotherapy drugs safe, with early signs of effectiveness

(19 Apr 2015)

AARC 2015: Combining Chk1 inhibition with standard dose gemcitabine may be safe and effective

(19 Apr 2015)

AACR 2015: Long-term, regular aspirin use modestly decreased cancer risk

(19 Apr 2015)

AACR 2015: CART-meso immunotherapy feasible for patients with advanced cancers

(19 Apr 2015)

AACR 2015: New immunotherapy yields long-lasting responses in some patients with advanced melanoma

(19 Apr 2015)

AACR 2015: Pembrolizumab safe, with signs of clinical benefit, for patients with malignant pleural mesothelioma

(19 Apr 2015)

AACR 2015: New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

(19 Apr 2015)

AACR 2015: Pembrolizumab is better than ipilimumab for advanced melanoma in phase III trial

(19 Apr 2015)

AACR 2015: Pembrolizumab promising for lung cancer, clinical outcomes correlate with biomarker

(19 Apr 2015)

Conferences Calendar

Information on upcoming conferences > find out where ecancer is filming next sign up for coverage submit your event

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation